Healthcare Services

Digital Therapeutics Sarcopenia Market Revenue Growth Expected to Reach $3.21 Billion by 2030 with 15.9% CAGR

April 1, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Digital Therapeutics Sarcopenia Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The digital therapeutics sarcopenia market size has experienced rapid growth in recent years. It is projected to expand from $1.54 billion in 2025 to $1.78 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.1%. This historical growth can be ascribed to factors such as the rising prevalence of the aging population, increased awareness regarding sarcopenia-related health risks, the expansion of telehealth adoption, growing acceptance of software-based medical therapies, and the early clinical validation of digital interventions.

The digital therapeutics sarcopenia market size is projected to experience substantial growth in the upcoming years, with an expectation to reach $3.21 billion by 2030, advancing at a compound annual growth rate (CAGR) of 15.9%. This anticipated growth is primarily driven by factors such as the increasing demand for home-based chronic condition management, the rising integration of AI-driven therapeutic personalization, the expansion of reimbursement support for digital therapeutics, the growing adoption of remote patient monitoring, and an increasing focus on preventive muscle health solutions. Major trends anticipated in this forecast period include the increasing adoption of personalized digital therapy programs, the rising use of wearable-integrated muscle monitoring, the growing deployment of remote physiotherapy platforms, the expansion of data-driven sarcopenia management solutions, and an enhanced focus on patient engagement and adherence.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27278&type=smp

What Major Drivers Are Influencing Demand In The Digital Therapeutics Sarcopenia Market?

The increasing incidence of comorbidities is anticipated to drive the expansion of the digital therapeutics sarcopenia market. Comorbidities are defined as the concurrent presence of two or more health issues within an individual. This rise in comorbidities is linked to an aging demographic, where older age naturally leads to a greater chance of developing several chronic conditions because of deteriorating bodily functions and prolonged exposure to health hazards. Digital therapeutics designed for sarcopenia offer advantages in averting comorbidities, particularly obesity, through encouraging consistent physical activity and muscle building, which in turn boosts metabolism and diminishes fat buildup. As an illustration, the World Obesity Federation, a UK-based membership organization, reported in March 2024 that by 2035, close to 79% of adults experiencing overweight and obesity are projected to reside in low- and middle-income countries, with the total count of obese adults estimated to reach 1.53 billion. Consequently, the growing frequency of comorbidities is fueling the expansion of the digital therapeutics sarcopenia market.

What Major Segment Divisions Exist Within The Digital Therapeutics Sarcopenia Market?

The digital therapeutics sarcopenia market covered in this report is segmented –

1) By Product: Software, Devices, Services

2) By Distribution Channel: Online Platforms, Direct-To-Consumer Digital Channels, Other Distribution Channels

3) By Application: Muscle Strengthening, Physical Activity Monitoring, Nutrition Management, Other Applications

4) By End User: Hospitals And Clinics, Homecare Settings, Rehabilitation Centers, Other End Users

Subsegments:

1) By Software: Mobile Applications, Web-Based Platforms, AI-Powered Monitoring Tools, Exercise And Rehabilitation Programs, Nutritional Guidance Software

2) By Devices: Wearable Fitness Trackers, Smart Scales, Connected Resistance Bands, Electromyography (EMG) Devices, Muscle Strength Assessment Tools

3) By Services: Remote Patient Monitoring Services, Virtual Physiotherapy Sessions, Teleconsultation Services, Personalized Coaching Services, Data Analytics And Reporting Services

What Major Market Trends Are Driving Changes In The Digital Therapeutics Sarcopenia Market?

Key players within the digital therapeutics sarcopenia market are concentrating on advancing solutions, particularly drug discovery platforms, to formulate more precise therapies, improve treatment efficacy, and speed up the provision of tailored care for muscle loss associated with aging. A drug discovery platform aids in the quicker and more effective identification and creation of new medications by utilizing advanced instruments and techniques. For example, in April 2025, ProFuse Technology, an Israel-based biotechnology enterprise, introduced a new drug discovery platform specifically targeting the prevention of muscle loss induced by GLP-1 weight-loss drugs, aging (sarcopenia), and cancer cachexia. By employing lab-cultivated, highly mature muscle tissues that emulate natural muscle, the company is able to accurately test and screen drug candidates with greater speed and efficiency. This sophisticated platform diminishes reliance on animal testing and reduces research expenditures. As therapies aimed at preserving muscle become more sought after, ProFuse is expanding its focus beyond cultivated meat into biopharma, providing an innovative strategy to address the increasing challenges related to muscle health.

Which Companies Are Leading Innovation In The Digital Therapeutics Sarcopenia Market?

Major companies operating in the digital therapeutics sarcopenia market are Sword Health Inc., Biofourmis Inc., Hinge Health Inc., Omada Health Inc., Evolv Rehabilitation Technologies Ltd., Click Therapeutics Inc., DarioHealth Corp., WellDoc Inc., Lark Technologies Inc., Kaia Health Software GmbH, Liva Healthcare A/S, Zibrio Inc., Gait Up SA, Noraxon Inc., Mira Rehab Limited, Cometa Srl., Koneksa Health Inc., Physitrack PLC, Kaia Health Inc., XRHealth USA Inc., MedRhythms Inc.

Read the full digital therapeutics sarcopenia market report here:

https://www.thebusinessresearchcompany.com/report/digital-therapeutics-sarcopenia-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Digital Therapeutics Sarcopenia Market?

North America was the largest region in the digital therapeutics sarcopenia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics sarcopenia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Digital Therapeutics Sarcopenia Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27278&type=smp

Browse Through More Reports Similar to the Global Digital Therapeutics Sarcopenia Market 2026, By The Business Research Company

Cutter Stapler Global Market Report

https://www.thebusinessresearchcompany.com/report/cutter-stapler-global-market-report

Battery Manufacturing Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/battery-manufacturing-equipment-global-market-report

Battery Separators Global Market Report

https://www.thebusinessresearchcompany.com/report/battery-separators-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795